Executive Search Success Story: Building a Global Leadership Team for a Connected Diabetes Device Manufacturer

How JRG Partners ran a confidential, multi-role search for a global manufacturer of insulin pumps and connected diabetes management systems. The strategy equipped the scaling enterprise with the critical global leadership required to accelerate innovation, scale manufacturing, and maintain patient safety across international markets.

The Challenge

A global medical device manufacturer specializing in insulin pumps and wearable diabetes management systems was scaling internationally amid demand for connected healthcare. It needed a global leadership team to accelerate innovation while maintaining patient safety. Leadership identified several strategic and operational pressures:

• Intense competition for experienced diabetes-device executives
• Increasing demand for connected healthcare and digital health solutions
• Complex global regulatory requirements and market approvals
• A need to scale manufacturing and supply chain operations efficiently
• Succession concerns among key technical and commercial leaders
• Pressure to accelerate innovation while maintaining patient safety and compliance

The mandate included confidential recruitment across Chief Operating Officer, Chief Technology Officer, VP Research & Development, VP Manufacturing Operations, VP Regulatory Affairs, VP Quality Assurance, commercial leadership, and global clinical affairs leaders. It needed a partner with deep connected-diabetes search expertise. For organizations evaluating how medical technology platforms expand commercial architectures across international lines, a parallel analysis can be reviewed in Diabetes_Insulin_Device_B_Whitelabeled.docx.

Why They Chose JRG Partners

Deep Connected-Diabetes Specialization

Our dedicated practices span connected diabetes management, insulin delivery, manufacturing, and global clinical affairs.

Real Access to Passive Talent

Many of the strongest connected-diabetes leaders are not actively looking. We drew on long-standing relationships and proprietary market intelligence to reach leaders invisible through conventional channels.

Confidential Search Execution

With international approvals and patient safety at stake, we ran a discreet process that protected continuity and confidence.

Global Reach

The search spanned major healthcare innovation centers across North America and Europe.

Our Corporate Search Strategy

Phase 1 — Leadership Assessment

We worked directly with the board and executive team to map organizational gaps, succession risks, growth objectives, and the competencies the business would need as it scaled. Profiles were built against the company’s long-term strategy rather than legacy job descriptions.

Phase 2 — Market Mapping

Our market map spanned diabetes care manufacturers, insulin delivery device companies, continuous glucose monitoring providers, digital health organizations, medical technology businesses, and biotechnology companies.

Phase 3 — Engagement

Our consultants discreetly engaged leaders with proven records in connected diabetes management. Only candidates with measurable impact advanced.

Phase 4 — Assessment & Selection

Each finalist went through extensive evaluation covering strategic and functional capability, leadership and team-building, cultural alignment, and long-term retention.

Key Outcomes

• 450+ senior executive and technical innovation profiles systematically mapped and evaluated across prime North American and European healthcare innovation hubs.
• Successfully executed a comprehensive, confidential multi-role leadership mandate within an accelerated 11-month timeline.
• Recruited high-impact leaders across COO, CTO, VP R&D, VP Manufacturing Operations, VP Regulatory Affairs, VP Quality Assurance, commercial, and clinical affairs roles.
• Bypassed conventional channels to secure passive talent from leading insulin delivery and continuous glucose monitoring networks.
• Replaced legacy job descriptions with forward-looking profiles tied explicitly to international regulatory approvals and digital health integration.
• Protected sensitive facility metrics and product formulation roadmaps through strict search confidentiality during a critical transition phase.
• Equipped the Board of Directors with a high-performance management framework primed to scale manufacturing and navigate global market approvals securely.